Association Between Diabetes Medications and the Risk of Parkinson's Disease: A Systematic Review and Meta-Analysis
出版年份 2021 全文链接
标题
Association Between Diabetes Medications and the Risk of Parkinson's Disease: A Systematic Review and Meta-Analysis
作者
关键词
-
出版物
Frontiers in Neurology
Volume 12, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2021-07-19
DOI
10.3389/fneur.2021.678649
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Does glitazone treatment have a role on the prevention of Parkinson’s disease in adult diabetic population? A systematic review
- (2020) Jesús D. Meléndez-Flores et al. METABOLIC BRAIN DISEASE
- Relationship of Cerebrospinal Fluid Vitamin B12 Status Markers With Parkinson's Disease Progression
- (2020) Chadwick W. Christine et al. MOVEMENT DISORDERS
- Association Between Glycemic Status and the Risk of Parkinson Disease: A Nationwide Population-Based Study
- (2020) Sang Youl Rhee et al. DIABETES CARE
- Thiazolidinedione use is associated with reduced risk of Parkinson’s disease in patients with diabetes: a meta-analysis of real-world evidence
- (2020) Salman Hussain et al. NEUROLOGICAL SCIENCES
- Association between metformin and neurodegenerative diseases of observational studies: systematic review and meta-analysis
- (2020) Fan Ping et al. BMJ Open Diabetes Research & Care
- Diabetes medications and risk of Parkinson’s disease: a cohort study of patients with diabetes
- (2020) Ruth Brauer et al. BRAIN
- Pioglitazone and statins lower incidence of Parkinson disease in patients with diabetes mellitus
- (2020) Y.‐Hu. Chang et al. EUROPEAN JOURNAL OF NEUROLOGY
- Metabolic Syndrome and Parkinson's Disease Incidence: A Nationwide Study Using Propensity Score Matching
- (2020) Ji-Hye Roh et al. Metabolic Syndrome and Related Disorders
- Effect of metformin on neurodegenerative disease among elderly adult US veterans with type 2 diabetes mellitus
- (2019) Qian Shi et al. BMJ Open
- WITHDRAWN: Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the International Diabetes Federation Diabetes Atlas, 9th edition
- (2019) Pouya Saeedi et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Diabetes mellitus and risks of cognitive impairment and dementia: A systematic review and meta-analysis of 144 prospective studies
- (2019) Mei Xue et al. AGEING RESEARCH REVIEWS
- Body mass index, diabetes, and the risk of Parkinson's disease
- (2019) Su‐Min Jeong et al. MOVEMENT DISORDERS
- Analysis of the Relationship between Type II Diabetes Mellitus and Parkinson’s Disease: A Systematic Review
- (2019) Fauze Camargo Maluf et al. Parkinsons Disease
- Association of thiazolidinedione with a lower risk of Parkinson’s disease in a population with newly-diagnosed diabetes mellitus
- (2018) Hsiu-Li Lin et al. ANNALS OF MEDICINE
- Insulin receptor in the brain: Mechanisms of activation and the role in the CNS pathology and treatment
- (2018) Igor Pomytkin et al. CNS Neuroscience & Therapeutics
- The Role of Glucagon in the Pathophysiology and Treatment of Type 2 Diabetes
- (2018) Sofie Hædersdal et al. MAYO CLINIC PROCEEDINGS
- Pioglitazone use and Parkinson’s disease: a retrospective cohort study in Taiwan
- (2018) Hsiu-Feng Wu et al. BMJ Open
- Epidemiology of Parkinson’s disease
- (2017) Ole-Bjørn Tysnes et al. JOURNAL OF NEURAL TRANSMISSION
- Exenatide once weekly versus placebo in Parkinson's disease: a randomised, double-blind, placebo-controlled trial
- (2017) Dilan Athauda et al. LANCET
- Glitazone use associated with reduced risk of Parkinson's disease
- (2017) Brage Brakedal et al. MOVEMENT DISORDERS
- Global aetiology and epidemiology of type 2 diabetes mellitus and its complications
- (2017) Yan Zheng et al. Nature Reviews Endocrinology
- Effects of metformin exposure on neurodegenerative diseases in elderly patients with type 2 diabetes mellitus
- (2017) Yi-Chun Kuan et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Long-term Metformin Use and Vitamin B12 Deficiency in the Diabetes Prevention Program Outcomes Study
- (2016) Vanita R. Aroda et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- The epidemiology of Parkinson's disease: risk factors and prevention
- (2016) Alberto Ascherio et al. LANCET NEUROLOGY
- Risk of Parkinson Disease in Diabetes Mellitus
- (2016) Xuejing Yue et al. MEDICINE
- Reduced incidence of Parkinson's disease after dipeptidyl peptidase-4 inhibitors-A nationwide case-control study
- (2016) Per Svenningsson et al. MOVEMENT DISORDERS
- Thiazolidinediones and Parkinson Disease: A Cohort Study
- (2015) John G. Connolly et al. AMERICAN JOURNAL OF EPIDEMIOLOGY
- Pioglitazone in early Parkinson's disease: a phase 2, multicentre, double-blind, randomised trial
- (2015) LANCET NEUROLOGY
- Glitazone Treatment and Incidence of Parkinson’s Disease among People with Diabetes: A Retrospective Cohort Study
- (2015) Ruth Brauer et al. PLOS MEDICINE
- Dynamic changes in pro- and anti-inflammatory cytokines in microglia after PPAR-γ agonist neuroprotective treatment in the MPTPp mouse model of progressive Parkinson's disease
- (2014) Augusta Pisanu et al. NEUROBIOLOGY OF DISEASE
- Metabolic inflammation exacerbates dopaminergic neuronal degeneration in response to acute MPTP challenge in type 2 diabetes mice
- (2013) Ling Wang et al. EXPERIMENTAL NEUROLOGY
- Exenatide and the treatment of patients with Parkinson’s disease
- (2013) Iciar Aviles-Olmos et al. JOURNAL OF CLINICAL INVESTIGATION
- Potential Role of Glucagon-Like Peptide-1 (GLP-1) in Neuroprotection
- (2012) Christian Hölscher CNS DRUGS
- Metformin-inclusive sulfonylurea therapy reduces the risk of Parkinson's disease occurring with Type 2 diabetes in a Taiwanese population cohort
- (2012) Mark L. Wahlqvist et al. PARKINSONISM & RELATED DISORDERS
- PARIS (ZNF746) Repression of PGC-1α Contributes to Neurodegeneration in Parkinson's Disease
- (2011) Joo-Ho Shin et al. CELL
- Diabetes and Risk of Parkinson's Disease
- (2011) Q. Xu et al. DIABETES CARE
- Insulin resistance impairs nigrostriatal dopamine function
- (2011) J.K. Morris et al. EXPERIMENTAL NEUROLOGY
- Risk-factors for Parkinson's disease: case-control study in the province of Cáceres, Spain
- (2010) A. Morano et al. ACTA NEUROLOGICA SCANDINAVICA
- Case–control study of risk of Parkinson's disease in relation to hypertension, hypercholesterolemia, and diabetes in Japan
- (2010) Yoshihiro Miyake et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Metformin Normalizes Type 2 Diabetes-Induced Decrease in Cell Proliferation and Neuroblast Differentiation in the Rat Dentate Gyrus
- (2010) In Koo Hwang et al. NEUROCHEMICAL RESEARCH
- Diabetes preceding Parkinson's disease onset. A case–control study
- (2009) Marco D'Amelio et al. PARKINSONISM & RELATED DISORDERS
- Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
- (2009) David Moher et al. PLOS MEDICINE
- Diabetes in Patients With Idiopathic Parkinson's Disease
- (2008) C. Becker et al. DIABETES CARE
- Prospective Cohort Study of Type 2 Diabetes and the Risk of Parkinson's Disease
- (2008) J. A. Driver et al. DIABETES CARE
- Metformin Protects the Brain Against the Oxidative Imbalance Promoted by Type 2 Diabetes
- (2008) Sonia Correia et al. Medicinal Chemistry
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now